۲ݮƵ

Thomas Durcan’s project will dissect the role of microglia in degenerative conditions, to identify new therapeutic strategies for Alzheimer's treatment

An innovative new program based at The Neuro has received $2.6 million from the CQDM and the Brain Canada Foundation.

Classified as: Neuro, Tom Durcan, Alzheimer's
Published on: 16 Oct 2024

MRI data from large sample shows increased whole-brain connectivity in people with a second language

Neuroplasticity is the brain’s ability to build connections within itself, adapting to the surrounding environment. The brain is most plastic in childhood, forming new pathways in reaction to stimuli such as language.

Classified as: Neuro, MNI, cognition, ACAR News
Published on: 11 Oct 2024

The 2024 Nobel Prize in Physiology or Medicine has been awarded to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation.

Category:
Published on: 8 Oct 2024

RNA Nanotechnology - Gordon Research Conference (GRC)

Controlling RNA Sequence for Diagnostics and Therapeutic Delivery

January 5 - 10, 2025

Ventura, California, United States

Category:
Published on: 8 Oct 2024

Scientists use stem cells to follow development of protein bodies characteristic of neurological disease

Classified as: Peter McPherson, Parkinson's, Neuro, MNI
Category:
Published on: 8 Oct 2024

Congratulations to Dr. Raquel Cuella Martin on receiving the prestigious Gairdner Foundation Early Career Investigator Award.

As an Assistant Professor of Human Genetics at ۲ݮƵ University, Dr. Cuella Martin is pushing the boundaries of science with her lab, which uses precision genome editing to tackle complex biological problems.

Category:
Published on: 3 Oct 2024

Génome Québec invests up to $500,000 to boost RNA therapeutics innovation in Quebec

Génome Québec, a private, non-profit organization dedicated to advancing genomics research and innovation in Quebec, is investing up to $500,000 in ۲ݮƵ University’s D2R Initiative. This investment will advance the commercialization of innovative genomic technologies in Quebec through D2R’s Commercialization Priming funding program.

Category:
Published on: 2 Oct 2024

Join ۲ݮƵ University Health Centre's next “Medical Genetics Grand Rounds”

The founder effect, which is observed in certain regions of Quebec, can increase susceptibility to rare disease. This stems from the fact that these communities were founded by populations that were already related.

Category:
Published on: 26 Sep 2024

D2R awards $7.3 million to Advance Research in Genomic-Based RNA Therapeutics

Montreal – September 17, 2024  ۲ݮƵ University’s D2R initiative is proud to announce the 23 recipients of its inaugural funding programs, Foundational Projects and Research in Motion. With a total investment of $7.3 million, these awards mark a significant milestone in advancing the field of genomic-based RNA therapeutics.

Category:
Published on: 17 Sep 2024

A recent article in La Presse, , highlights how Quebec's life sciences sector is experiencing a significant revival with the creation of an RNA hub.

Here is a exerpt from the article (translated to english): 

Category:
Published on: 13 Sep 2024

The ۲ݮƵ community, including researchers in genomic medicine and the health sciences, came together in July 2024 to mark the next phase of one of the University’s most rapidly growing disciplines and celebrate the generosity that is making it possible. 

The occasion was the official unveiling of signage for the Victor Phillip Dahdaleh Institute of Genomic Medicine, and on hand were the Institute’s UK-based benefactors, Victor and Mona Dahdaleh, who were recognized for the far-reaching power of their philanthropy.

Category:
Published on: 19 Aug 2024

Discover how lipid are transforming gene therapy in a new article co-authored by Pieter Cullis, Professor, Biochemistry and Molecular Biology at The University of British Columbia.

Category:
Published on: 11 Jul 2024

In a press release published by the Global Alliance for Genomics and Health (GA4GH), it was announced that the Victor Phillip Dahdaleh Institute of Genomic Medicine at ۲ݮƵ University has joined the alliance as a Host Institution. GA4GH is a not-for-profit alliance uniting the international community dedicated to advancing human health through genomic data.

Category:
Published on: 20 Jun 2024

Imagine a world where your unique genetic makeup can be used to tailor your medical care, and where illnesses and disease are treated with pinpoint accuracy.

On June 11, 2024 three ۲ݮƵ professors at the forefront of the genomic revolution discuss in this webcast the opportunities and ethical pitfalls behind genetics, immunotherapy and personalized medicine. They discuss the various ways in which these scientific advances promise to revolutionize how we think about and treat diseases, from diabetes to cancer.

𲹰:

Category:
Published on: 13 Jun 2024

On June 3, 2024, CQDM, in collaboration with Axelys, Montréal InVivo and RNA Québec introduced AReNA, a new RNA hub in Quebec. Unveiled at the BIO conference in San Diego, in the presence of the Minister for the Economy, the Minister responsible for the Fight Against Racism, and the Minister responsible for the Laval region, Mr. Christopher Skeete, this initiative seeks to bring together key players in life sciences and aims to propel Quebec to the forefront of innovation in the field of RNA therapies.

Category:
Published on: 13 Jun 2024

Pages

Back to top